Article citationsMore>>

U.S. Department of Health and Human Services, Food and Drug Administration and Centre for Drug Evaluation and Research (CDER) (2021) Control of Nitrosamine Impurities in Human Drugs, Guidance for Industry. Pharmaceutical Quality/Manufacturing Standards/Current Good Manufacturing Practice (CGMP) Revision 1.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top